Health-Related Quality of Life Before and After Use of a Smartphone App for Adolescents and Young Adults With Cancer: Pre-Post Interventional Study.
adolescent
cancer
mHealth
quality of life
smartphone
survivorship
young adult
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
03 10 2019
03 10 2019
Historique:
received:
26
02
2019
accepted:
21
07
2019
revised:
06
06
2019
entrez:
5
10
2019
pubmed:
5
10
2019
medline:
25
8
2020
Statut:
epublish
Résumé
Adolescent and young adult (AYA) patients with cancer are a group with underexplored needs throughout treatment and in survivorship. This missing knowledge can influence their quality of life (QoL). Given this fact, we have developed a smartphone app based on a cocreation process and have an investigation of QoL among users planned as part of pilot testing this app. Future research is warranted to determine the effect of mobile health (mHealth) tools such as smartphone apps among the AYA cancer population. The aim of this study was to investigate the feasibility of a smartphone app among AYA patients with cancer in active treatment and posttreatment, in a pilot test by measuring health-related QoL before and after the use of the app. Participants were recruited via the youth support initiative and social organization for AYAs with cancer, Kræftværket, based at Rigshospitalet, University Hospital of Copenhagen, Denmark. Participants were evenly distributed in active treatment and posttreatment groups. After written informed consent, all participants were asked to use the app Kræftværket as they deemed appropriate over a 6-week period. The participants were asked to complete the 30-item European Organization for Research and Treatment of Cancer Quality of Life Questionnaire before and after the 6-week period. The collected QoL data were analyzed with t tests to determine differences between groups and from baseline. In total, we enrolled 20 participants, 10 in active treatment and 10 posttreatment (median time after treatment was 4 months) group. Median age of the participants was 25 years. No differences in QoL were seen at baseline (P=.65). The posttreatment group experienced a significant increase in overall QoL after the 6-week period (global QoL: baseline 62.5, SD 22.3; after 6 weeks 80.8, SD 9.7; P=.04). For the group in active treatment, the QoL remained stable throughout the 6 weeks. This study shows the feasibility and possible effect on QoL associated with the use of an mHealth tool in AYA patients. mHealth support tools are warranted for this population.
Sections du résumé
BACKGROUND
Adolescent and young adult (AYA) patients with cancer are a group with underexplored needs throughout treatment and in survivorship. This missing knowledge can influence their quality of life (QoL). Given this fact, we have developed a smartphone app based on a cocreation process and have an investigation of QoL among users planned as part of pilot testing this app. Future research is warranted to determine the effect of mobile health (mHealth) tools such as smartphone apps among the AYA cancer population.
OBJECTIVE
The aim of this study was to investigate the feasibility of a smartphone app among AYA patients with cancer in active treatment and posttreatment, in a pilot test by measuring health-related QoL before and after the use of the app.
METHODS
Participants were recruited via the youth support initiative and social organization for AYAs with cancer, Kræftværket, based at Rigshospitalet, University Hospital of Copenhagen, Denmark. Participants were evenly distributed in active treatment and posttreatment groups. After written informed consent, all participants were asked to use the app Kræftværket as they deemed appropriate over a 6-week period. The participants were asked to complete the 30-item European Organization for Research and Treatment of Cancer Quality of Life Questionnaire before and after the 6-week period. The collected QoL data were analyzed with t tests to determine differences between groups and from baseline.
RESULTS
In total, we enrolled 20 participants, 10 in active treatment and 10 posttreatment (median time after treatment was 4 months) group. Median age of the participants was 25 years. No differences in QoL were seen at baseline (P=.65). The posttreatment group experienced a significant increase in overall QoL after the 6-week period (global QoL: baseline 62.5, SD 22.3; after 6 weeks 80.8, SD 9.7; P=.04). For the group in active treatment, the QoL remained stable throughout the 6 weeks.
CONCLUSIONS
This study shows the feasibility and possible effect on QoL associated with the use of an mHealth tool in AYA patients. mHealth support tools are warranted for this population.
Identifiants
pubmed: 31584008
pii: v7i10e13829
doi: 10.2196/13829
pmc: PMC6797966
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13829Informations de copyright
©Helle Pappot, Gry Assam Taarnhøj, Abbey Elsbernd, Maiken Hjerming, Signe Hanghøj, Marc Jensen, Kirsten Arntz Boisen. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 03.10.2019.
Références
J Med Internet Res. 2015 Dec 23;17(12):e287
pubmed: 26701961
J Med Internet Res. 2013 May 21;15(5):e95
pubmed: 23697600
Qual Life Res. 2014 May;23(4):1377-86
pubmed: 24197479
J Cancer Surviv. 2013 Dec;7(4):523-34
pubmed: 23749663
Eur J Cancer Care (Engl). 2011 Mar;20(2):145-51
pubmed: 20477855
Qual Life Res. 2013 Feb;22(1):111-8
pubmed: 22286223
Am J Community Psychol. 1995 Oct;23(5):581-99
pubmed: 8851341
Semin Oncol. 2009 Jun;36(3):275-80
pubmed: 19460584
JMIR Mhealth Uhealth. 2017 Oct 23;5(10):e124
pubmed: 29061552
JMIR Cancer. 2020 Jan 2;6(1):e15008
pubmed: 31895046
Curr Oncol Rep. 2013 Aug;15(4):325-31
pubmed: 23700032
Stud Health Technol Inform. 2016;228:205-9
pubmed: 27577372
ESMO Open. 2017 Sep 8;2(4):e000252
pubmed: 29018578
Online J Public Health Inform. 2015 Jul 01;7(2):e218
pubmed: 26392848
JMIR Res Protoc. 2018 May 10;7(5):e10098
pubmed: 29748162
J Med Internet Res. 2013 Dec 23;15(12):e287
pubmed: 24366061
Psychooncology. 2016 Dec;25(12):1408-1417
pubmed: 26810123
J Med Internet Res. 2017 Jun 07;19(6):e196
pubmed: 28592394
J Behav Addict. 2015 Dec;4(4):299-307
pubmed: 26690625
Eur J Cancer Care (Engl). 2017 Mar;26(2):
pubmed: 27007727
Adolesc Health Med Ther. 2015 Aug 18;6:141-8
pubmed: 26316835
J Clin Oncol. 2004 Feb 15;22(4):714-24
pubmed: 14966096
J Adolesc Young Adult Oncol. 2019 Feb;8(1):98-102
pubmed: 30394824
Patient Relat Outcome Meas. 2015 Feb 17;6:19-51
pubmed: 25733941
J Adolesc Young Adult Oncol. 2011 Sep;1(3):124-132
pubmed: 23610733
Eur J Cancer Care (Engl). 2018 Nov;27(6):e12972
pubmed: 30485604
J Adolesc Young Adult Oncol. 2018 Aug;7(4):453-464
pubmed: 29565709
JMIR Form Res. 2018 Nov 01;2(2):e23
pubmed: 30684439
Qual Life Res. 2017 Jul;26(7):1659-1672
pubmed: 28251543
Cancer. 2017 Oct 15;123(20):4039-4047
pubmed: 28696580